Digipath Inc (DIGP)

[europa7]

looks like the new DIGP CEO and Director are in place, which is good news. found some background info that might be of interest:

RBC Hemp LLC
http://rbchemp.com/management/
(Kyle Remenda bio listed on this company page...very interesting)

Mergers & Acquisitions
https://aol.theonlineinvestor.com/slideshows/?slideshow=mergers&page=44

Classification of Cannabis Chemovars Using Targeted Single Nucleotide Polymorphism Assays Philippe Henry , PH.D./CSO VSSL

The genetic basis of the human-cannabis relationship
https://www.biorxiv.org/content/biorxiv/early/2018/03/27/287938.full.pdf

Predicting chemovar cluster and variety verification invegetative cannabis accessions using targeted singlenucleotide polymorphisms
https://peerj.com/preprints/27442.pdf

Integrative Cannabis Medicine: the science of making cannabis work better for you
https://www.eventbrite.ca/e/integrative-cannabis-medicine-the-science-of-making-cannabis-work-better-for-you-tickets-58287691053#

Join us for a discussion on Medical Cannabis with
Dr Chris Spooner ND and
Dr Philippe Henry, PhD Biology
Tim Dyer, Registered Pharmacist

Philippe Henry, PhD, is the founder and Chief Science Officer with VSSL Enterprises LTd. He is a population geneticist who uses genomic data to advance the understanding of the genetic basis of key traits of the cannabis plant and its therapeutic potential. Dr. Henry’s recent work has focused on the development of statistical approaches to modeling the chemotypic variation in elite cannabis cultivars and correlating that information with genomic data with the goal of using sound science to objectively guide cannabis breeding efforts and product development. Along with numerous published papers in scientific journals, Dr. Henry is the co-author of a recent preprint article, “Predicting chemovar cluster and variety verification in vegetative cannabis accessions using targeted single nucleotide polymorphisms” (https://peerj.com/preprints/27442/).

His talk will focus on the interface between cannabis chemotypes and the underlying basis of people’s responses to cannabis as a therapeutic agent and recreational substance

Leysin Scientific
http://web.unbc.ca/~henryp/Leysin_scientific.html